ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Clinical trials for ADVANCED HEPATOCELLULAR CARCINOMA (HCC) explained in plain language.
Never miss a new study
Get alerted when new ADVANCED HEPATOCELLULAR CARCINOMA (HCC) trials appear
Sign up with your email to follow new studies for ADVANCED HEPATOCELLULAR CARCINOMA (HCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New 'Super' immune cell therapy tested for tough liver cancers
Disease control Recruiting nowThis is an early-stage safety study testing a new type of personalized immune cell therapy for patients with advanced liver cancer. The therapy, called Super CAR-T, involves collecting a patient's own immune cells, modifying them in a lab to better target their cancer, and then i…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Phase: PHASE1 • Sponsor: Guangzhou FineImmune Biotechnology Co., LTD. • Aim: Disease control
Last updated Apr 04, 2026 03:21 UTC
-
Two-Target immune cell therapy fights tough liver cancers
Disease control Recruiting nowThis early-stage trial is testing a new type of cell therapy for adults with advanced liver cancer that has stopped responding to standard treatments. Researchers are using specially engineered immune cells (CAR-NK cells) designed to recognize and attack cancer cells using two di…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated Apr 04, 2026 03:20 UTC
-
Radiation boost for liver cancer immunotherapy?
Disease control Recruiting nowThis study is testing whether adding a targeted form of radiation therapy (particle beam) to standard immunotherapy helps people with advanced liver cancer that has grown into major blood vessels. It will enroll 128 participants to see if the combination is safe and more effectiv…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: National Cancer Center, Korea • Aim: Disease control
Last updated Apr 04, 2026 03:20 UTC
-
Experimental immune cell therapy tested in Tough-to-Treat liver cancer
Disease control Recruiting nowThis is an early-stage study testing a new type of personalized immune cell therapy (called CAR-T) for people with advanced liver cancer that has stopped responding to standard treatments. Doctors will collect a patient's own immune cells, modify them in a lab to target a specifi…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Phase: NA • Sponsor: Zhejiang University • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New drug combo tested for Tough-to-Treat liver cancer
Disease control Recruiting nowThis study is testing whether adding an experimental drug called WGI-0301 to the standard drug sorafenib can help control advanced liver cancer. It is for adults whose cancer has worsened after trying a previous type of immunotherapy. The main goals are to find the safest dose of…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: Zhejiang Haichang Biotech Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Supercharged immune cells take aim at tough liver cancers
Disease control Recruiting nowThis study is testing a new type of personalized cell therapy for patients with advanced liver cancer that has come back or stopped responding to other treatments. Doctors will collect a patient's own immune cells, genetically modify them in a lab to better recognize and attack u…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Phase: PHASE1, PHASE2 • Sponsor: Eastern Hepatobiliary Surgery Hospital • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC